Summary
CMS recently passed its long-awaited prior authorization final rule (CMS-0057-F), which is poised to reshape prior authorization. With rapidly approaching deadlines, payers need a roadmap to ensure compliance with the requirements around transparency, turnaround times, interoperability, and accountability. And the countdown has begun. Join us to learn how leading payers are preparing for the deadlines with AI-driven, intelligent prior authorization.
Watch this session to learn:
-
What’s ultimately included in the final rule–and crucial deadlines
- Ways to get ahead of compliance (and effectively tackle the most common challenges)
- How to use intelligent prior authorization to elevate and speed up your approach to meeting and even surpassing the new UM requirements
About Cohere Health
Cohere is a clinical intelligence company that is transforming utilization management (UM) by aligning physicians and health plans on evidence-based care paths for the patient’s entire care journey. By integrating these care paths into the prior authorization submission process, Cohere’s digital UM collaboration platform reduces denial rates and medical expenses while improving patient outcomes. The company is a winner of the TripleTree iAward and has been named to both Fierce Healthcare’s Fierce 15 and CB Insights’ Digital Health 150 lists. Cohere’s investors include Flare Capital Partners, Define Ventures, Deerfield, Polaris Partners, and Longitude Capital.
